1. Home
  2. IBRX vs FCFS Comparison

IBRX vs FCFS Comparison

Compare IBRX & FCFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$7.26

Market Cap

8.4B

Sector

Health Care

ML Signal

HOLD

Logo FirstCash Holdings Inc.

FCFS

FirstCash Holdings Inc.

HOLD

Current Price

$200.42

Market Cap

8.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
FCFS
Founded
2014
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Other Specialty Stores
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
8.4B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
IBRX
FCFS
Price
$7.26
$200.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
3
Target Price
$12.57
$191.00
AVG Volume (30 Days)
22.2M
306.3K
Earning Date
05-11-2026
04-23-2026
Dividend Yield
N/A
0.84%
EPS Growth
38.71
29.49
EPS
N/A
7.42
Revenue
$113,288,000.00
$3,661,043,000.00
Revenue This Year
$88.59
$16.20
Revenue Next Year
$131.15
$8.35
P/E Ratio
N/A
$26.98
Revenue Growth
668.31
8.04
52 Week Low
$1.83
$116.66
52 Week High
$12.43
$202.25

Technical Indicators

Market Signals
Indicator
IBRX
FCFS
Relative Strength Index (RSI) 46.21 62.75
Support Level $5.89 $178.78
Resistance Level $8.28 N/A
Average True Range (ATR) 0.94 6.58
MACD -0.21 -0.26
Stochastic Oscillator 25.33 88.74

Price Performance

Historical Comparison
IBRX
FCFS

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About FCFS FirstCash Holdings Inc.

FirstCash Holdings Inc is an operator of pawn stores in the U.S., Latin America and the U.K. The company's primary line of business is the operation of retail pawn stores, also known as pawnshops. It also operates a retail POS payment solutions business. Its two business lines are organized into four reportable segments: The U.S. pawn segment consists of pawn operations in some of U.S. states and the District of Columbia; The Latin America pawn segment consists of pawn operations in Mexico, Guatemala, El Salvador and Colombia; The U.K. pawn segment consists of pawn operations in England, Scotland and Wales; and The retail POS payment solutions segment consists of the operations of American First Finance, LLC, which offers products in the U.S.

Share on Social Networks: